Effect of Aplidin on Acute Lymphoblastic Leukaemia Cells
Author Information
Author(s): Erba E, Serafini M, Gaipa G, Tognon G, Marchini S, Celli N, Rotilio D, Broggini M, Jimeno J, Faircloth G T, Biondi A, D'Incalci M
Primary Institution: Istituto di Ricerche Farmacologiche ‘Mario Negri’
Hypothesis
Can Aplidin effectively induce apoptosis in acute lymphoblastic leukaemia cells?
Conclusion
Aplidin is a potent antileukaemic agent that induces significant apoptosis in acute lymphoblastic leukaemia cells.
Supporting Evidence
- Aplidin was effective at nanomolar concentrations in all tested leukaemic cell lines.
- The cytotoxic effect of Aplidin was dose-dependent.
- Aplidin induced apoptosis in all leukaemic cell lines tested.
- Cell death ranged from 74% to 100% at 5 nM concentration of Aplidin.
- Patients with adverse genetic features were sensitive to Aplidin.
- Aplidin maintained its efficacy in both newly diagnosed and relapsed cases.
Takeaway
Aplidin is a medicine that helps kill cancer cells in kids with a type of blood cancer called acute lymphoblastic leukaemia.
Methodology
The study assessed the cytotoxic effect of Aplidin on fresh leukaemia cells from children using a stroma-supported culture system and various leukaemic cell lines.
Potential Biases
Potential bias in patient selection and the influence of stroma on drug efficacy.
Limitations
The study may not fully represent all genetic variations of acute lymphoblastic leukaemia due to the limited sample size.
Participant Demographics
Patients aged 1 to 14 years with B-cell-precursor acute lymphoblastic leukaemia.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website